Dr. Emad Ibrahim, Senior Consultant and Microbiology Division Head, Hamad Medical Corporation, Qatar
Dr. Emad Ibrahim obtained his FRCPath from the Royal College of Pathologists in London and was the country advisor for the organisation between 2015 to 2023. He is the head of the Clinical Microbiology & Virology division at Hamad Medical Corporation; Chairperson at the Infection Prevention and Control unit at the Heart Hospital; and is the head of Quality Cluster. Dr. Ibrahim is also part of the lead quality and infection control teams during JCI and CAP inspections.
Dr. Ibrahim’s early experience includes working as a clinical consultant microbiologist and virologist at various hospitals in UK, including Southmead Hospital, Frenchay Hospital, Bristol Royal Infirmary, Western General Hospital and Ealing Hospital in London. His roles were direct clinical care positions, as well as laboratory management, health protection, protocol and guidance development, infection control and training supervision.
His research interests are multidisciplinary with emphasis on diagnostic approaches, epidemiology, antimicrobial susceptibility resistance and infection control, and ‘one Health Approach”.
His research efforts includes the development and evaluation of rapid and molecular techniques for diagnosis of significant infections. More recently, he participated in publishing a study using real time multiplex PCR for identification of enteric pathogens and whole genome sequencing for detection resistance among MDRO pseudomonas and detecting MRC genes responsible for colistin resistance.
Dr. Ibrahim is an active member of several local, corporate and national committees and participates in the national action plan to combat antimicrobial resistance and WHO GLASS surveillance.
He is currently an associate professor at the Biomedical Research Center (BRC), Qatar University, assistant professor at Weill Cornell Medical College and was previously a lecturer at the School of Cellular and Molecular Medicine-University of Bristol.
